{"name":"LG Life Sciences","slug":"lg-life-sciences","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":18,"colorKey":"oncology","drugs":[{"name":"Apetrol ES","genericName":"Apetrol ES","slug":"apetrol-es","indication":"Other","status":"phase_1"},{"name":"LC23-1306","genericName":"LC23-1306","slug":"lc23-1306","indication":"Other","status":"phase_1"},{"name":"rosuvastatin only","genericName":"rosuvastatin only","slug":"rosuvastatin-only","indication":"Other","status":"phase_1"},{"name":"Eutravac","genericName":"Eutravac","slug":"eutravac","indication":"Other","status":"phase_3"},{"name":"Eutropin","genericName":"Eutropin","slug":"eutropin","indication":"Other","status":"phase_3"},{"name":"Growth hormone - LB03002","genericName":"Growth hormone - LB03002","slug":"growth-hormone-lb03002","indication":"Other","status":"phase_3"},{"name":"Hiberix™ Vaccine","genericName":"Hiberix™ Vaccine","slug":"hiberix-vaccine","indication":"Prevention of invasive Haemophilus influenzae type b disease in infants and children","status":"phase_3"},{"name":"IVF-M HP Inj.","genericName":"IVF-M HP Inj.","slug":"ivf-m-hp-inj","indication":"Anovulation or oligoovulation in women with polycystic ovary syndrome (PCOS) undergoing assisted reproduction","status":"marketed"},{"name":"Kytril inj.+Kytril tab.","genericName":"Kytril inj.+Kytril tab.","slug":"kytril-inj-kytril-tab","indication":"Chemotherapy-induced nausea and vomiting (CINV)","status":"marketed"},{"name":"LBAL","genericName":"LBAL","slug":"lbal","indication":"Other","status":"phase_3"},{"name":"LBEC0101","genericName":"LBEC0101","slug":"lbec0101","indication":"Other","status":"phase_3"},{"name":"LBVH0101 (Hib vaccine)","genericName":"LBVH0101 (Hib vaccine)","slug":"lbvh0101-hib-vaccine","indication":"Prevention of invasive Haemophilus influenzae type b disease (meningitis, bacteremia, epiglottitis)","status":"phase_3"},{"name":"LC28-0126 Dose C","genericName":"LC28-0126 Dose C","slug":"lc28-0126-dose-c","indication":"Other","status":"phase_2"},{"name":"Levacalm","genericName":"Levacalm","slug":"levacalm","indication":"Other","status":"phase_2"},{"name":"Menopur® Inj.","genericName":"Menopur® Inj.","slug":"menopur-inj","indication":"Ovulation induction in anovulatory women","status":"marketed"},{"name":"Placebo group(once daily)","genericName":"Placebo group(once daily)","slug":"placebo-group-once-daily","indication":"Other","status":"phase_3"},{"name":"Sancuso patch","genericName":"Sancuso patch","slug":"sancuso-patch","indication":"Prevention of nausea and vomiting associated with emetogenic chemotherapy","status":"marketed"},{"name":"Zofran inj.+Zofran tab.","genericName":"Zofran inj.+Zofran tab.","slug":"zofran-inj-zofran-tab","indication":"Chemotherapy-induced nausea and vomiting (CINV)","status":"marketed"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"immunology","drugs":[{"name":"LBSA0103","genericName":"LBSA0103","slug":"lbsa0103","indication":"Type 2 diabetes","status":"phase_3"},{"name":"Gemigliptin and/or Rosuvastatin","genericName":"Gemigliptin and/or Rosuvastatin","slug":"gemigliptin-and-or-rosuvastatin","indication":"Type 2 diabetes mellitus with dyslipidemia","status":"phase_3"},{"name":"Gemigliptin/Glimepiride combination","genericName":"Gemigliptin/Glimepiride combination","slug":"gemigliptin-glimepiride-combination","indication":"Type 2 diabetes mellitus","status":"phase_3"},{"name":"Placebo to Linagliptin","genericName":"Placebo to Linagliptin","slug":"placebo-to-linagliptin","indication":"Type 2 diabetes","status":"phase_3"},{"name":"Placebo(Gemigliptin)","genericName":"Placebo(Gemigliptin)","slug":"placebo-gemigliptin","indication":"Type 2 diabetes mellitus","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"Enbrel","genericName":"Enbrel","slug":"enbrel","indication":"Ankylosing spondylitis","status":"marketed"},{"name":"Hyruan Plus","genericName":"Hyruan Plus","slug":"hyruan-plus","indication":"Osteoarthritis of the knee","status":"phase_3"}]}],"pipeline":[{"name":"Apetrol ES","genericName":"Apetrol ES","slug":"apetrol-es","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"LBSA0103","genericName":"LBSA0103","slug":"lbsa0103","phase":"phase_3","mechanism":"LBSA0103 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"LC23-1306","genericName":"LC23-1306","slug":"lc23-1306","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"rosuvastatin only","genericName":"rosuvastatin only","slug":"rosuvastatin-only","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Enbrel","genericName":"Enbrel","slug":"enbrel","phase":"marketed","mechanism":"Tumor necrosis factor","indications":["Ankylosing spondylitis","Juvenile idiopathic arthritis","Nonradiographic axial spondyloarthritis","Plaque psoriasis","Psoriasis with arthropathy"],"catalyst":""},{"name":"Eutravac","genericName":"Eutravac","slug":"eutravac","phase":"phase_3","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Eutropin","genericName":"Eutropin","slug":"eutropin","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Gemigliptin and/or Rosuvastatin","genericName":"Gemigliptin and/or Rosuvastatin","slug":"gemigliptin-and-or-rosuvastatin","phase":"phase_3","mechanism":"Gemigliptin inhibits dipeptidyl peptidase-4 (DPP-4) to increase incretin levels and improve glycemic control, while rosuvastatin inhibits HMG-CoA reductase to lower cholesterol.","indications":["Type 2 diabetes mellitus with dyslipidemia"],"catalyst":""},{"name":"Gemigliptin/Glimepiride combination","genericName":"Gemigliptin/Glimepiride combination","slug":"gemigliptin-glimepiride-combination","phase":"phase_3","mechanism":"Gemigliptin inhibits dipeptidyl peptidase-4 (DPP-4) to increase incretin levels and insulin secretion, while glimepiride stimulates pancreatic beta cells to release insulin directly.","indications":["Type 2 diabetes mellitus"],"catalyst":""},{"name":"Growth hormone - LB03002","genericName":"Growth hormone - LB03002","slug":"growth-hormone-lb03002","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Hiberix™ Vaccine","genericName":"Hiberix™ Vaccine","slug":"hiberix-vaccine","phase":"phase_3","mechanism":"Hiberix is a conjugate vaccine that stimulates the immune system to produce antibodies against Haemophilus influenzae type b (Hib) by linking the bacterial polysaccharide capsule to a protein carrier.","indications":["Prevention of invasive Haemophilus influenzae type b disease in infants and children"],"catalyst":""},{"name":"Hyruan Plus","genericName":"Hyruan Plus","slug":"hyruan-plus","phase":"phase_3","mechanism":"Hyruan Plus is a viscoelastic hyaluronic acid-based injection that provides lubrication and cushioning to damaged joints.","indications":["Osteoarthritis of the knee"],"catalyst":""},{"name":"IVF-M HP Inj.","genericName":"IVF-M HP Inj.","slug":"ivf-m-hp-inj","phase":"marketed","mechanism":"IVF-M HP is a recombinant human follicle-stimulating hormone (FSH) that stimulates ovarian follicle development and estrogen production in women undergoing assisted reproductive therapy.","indications":["Anovulation or oligoovulation in women with polycystic ovary syndrome (PCOS) undergoing assisted reproduction","Controlled ovarian hyperstimulation for in vitro fertilization (IVF)","Ovulation induction in infertile women"],"catalyst":""},{"name":"Kytril inj.+Kytril tab.","genericName":"Kytril inj.+Kytril tab.","slug":"kytril-inj-kytril-tab","phase":"marketed","mechanism":"Granisetron blocks serotonin 5-HT3 receptors on chemoreceptor trigger zone and vagal afferent nerves to prevent nausea and vomiting.","indications":["Chemotherapy-induced nausea and vomiting (CINV)","Postoperative nausea and vomiting (PONV)","Radiation-induced nausea and vomiting"],"catalyst":""},{"name":"LBAL","genericName":"LBAL","slug":"lbal","phase":"phase_3","mechanism":"LBAL is a therapeutic agent in development by LG Life Sciences, currently in phase 3 clinical trials.","indications":[],"catalyst":""},{"name":"LBEC0101","genericName":"LBEC0101","slug":"lbec0101","phase":"phase_3","mechanism":"LBEC0101 is a therapeutic candidate in phase 3 development by LG Life Sciences with an undisclosed or proprietary mechanism of action.","indications":[],"catalyst":""},{"name":"LBVH0101 (Hib vaccine)","genericName":"LBVH0101 (Hib vaccine)","slug":"lbvh0101-hib-vaccine","phase":"phase_3","mechanism":"LBVH0101 is a Haemophilus influenzae type b (Hib) conjugate vaccine that stimulates the immune system to produce antibodies against Hib polysaccharide capsule.","indications":["Prevention of invasive Haemophilus influenzae type b disease (meningitis, bacteremia, epiglottitis)"],"catalyst":""},{"name":"LC28-0126 Dose C","genericName":"LC28-0126 Dose C","slug":"lc28-0126-dose-c","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Levacalm","genericName":"Levacalm","slug":"levacalm","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Menopur® Inj.","genericName":"Menopur® Inj.","slug":"menopur-inj","phase":"marketed","mechanism":"Menopur is a purified preparation of human menopausal gonadotropins (hMG) containing follicle-stimulating hormone (FSH) and luteinizing hormone (LH) that stimulates ovarian follicle development and hormone production in women undergoing fertility treatment.","indications":["Ovulation induction in anovulatory women","Controlled ovarian hyperstimulation in assisted reproductive technology (ART) cycles","Spermatogenesis stimulation in hypogonadal men"],"catalyst":""},{"name":"Placebo group(once daily)","genericName":"Placebo group(once daily)","slug":"placebo-group-once-daily","phase":"phase_3","mechanism":"A placebo contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect.","indications":[],"catalyst":""},{"name":"Placebo to Linagliptin","genericName":"Placebo to Linagliptin","slug":"placebo-to-linagliptin","phase":"phase_3","mechanism":"Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which increases the levels of incretin hormones, thereby enhancing glucose-dependent insulin secretion.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"Placebo(Gemigliptin)","genericName":"Placebo(Gemigliptin)","slug":"placebo-gemigliptin","phase":"phase_3","mechanism":"Gemigliptin inhibits dipeptidyl peptidase-4 (DPP-4) to increase incretin levels and improve blood glucose control in type 2 diabetes.","indications":["Type 2 diabetes mellitus"],"catalyst":""},{"name":"Sancuso patch","genericName":"Sancuso patch","slug":"sancuso-patch","phase":"marketed","mechanism":"Sancuso is a granisetron transdermal patch that blocks serotonin 5-HT3 receptors in the chemoreceptor trigger zone and gastrointestinal tract to prevent nausea and vomiting.","indications":["Prevention of nausea and vomiting associated with emetogenic chemotherapy","Prevention of postoperative nausea and vomiting (PONV)"],"catalyst":""},{"name":"Zofran inj.+Zofran tab.","genericName":"Zofran inj.+Zofran tab.","slug":"zofran-inj-zofran-tab","phase":"marketed","mechanism":"Ondansetron blocks serotonin (5-HT3) receptors on chemoreceptor trigger zone and vagal afferent nerves to prevent nausea and vomiting.","indications":["Chemotherapy-induced nausea and vomiting (CINV)","Post-operative nausea and vomiting (PONV)","Radiation-induced nausea and vomiting"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxPOGhDdC1velNDTXluMGRYcm92a1dTVlp0N1FjdU1vbXJHVDd6eXVHNE1DWHplNmlFTzdEcWNPUUZjR2UtVjFMZzFCczZrYnFvUUF4TnUxZlpkY25FazRUV2duVVBDWWh1NnNTUVltZmVQbjFKYWprUFF5ekRJVlZmbjR5TVYya1paN195ZmVpdWxEVDgxaUFMckZYTTVFZ3VoYldWdTdBZk03eHB3bmQ0Vk90X2dvSGFMbHNsaDdhemFKVHBYWk8zU3BnUkNZNUJIelJDcEpwbGozMkJfNnpkaThQMUpKTXhHel9iVmduUGVaV0FYaUNUYjU3Ql93T1NQ?oc=5","date":"2026-04-03","type":"pipeline","source":"mykxlg.com","summary":"Innate Pharma to Participate in the Kempen Life Sciences Conference - mykxlg.com","headline":"Innate Pharma to Participate in the Kempen Life Sciences Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBoY0dkam9qWWVfXzFQSFFLeDRXSENNa0g5enJ4SGNxRUhQdnJlbGV3NlN3MThDeXhGTngzY0szQ1dBYlE1VXJpSVpaZEY4aFJQTU0tNlMzMkRaTWR1RzB6ZzUxNVE5WHJpVDljSE530gFyQVVfeXFMTUtveFpGTU1kcG1tZGw2Sk1vUDlXMWlqM3R1emwzaHUxZXI4ckMzMnpJQ3B6MkFrNXlMRjFQSm1VVGlGRGJ6blFZWElrdmxmUG5VN1RoUG1YelpnZlRTb0ExMU03VW9BVTVQcUFweHRsdlBn?oc=5","date":"2026-04-03","type":"pipeline","source":"koreabiomed.com","summary":"LG Chem signs Korea, Thailand rights to Mochida’s endometriosis drug Dinagest - koreabiomed.com","headline":"LG Chem signs Korea, Thailand rights to Mochida’s endometriosis drug Dinagest","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFBjdUMtT3pHaTQxSlRsY2dWQ1JXbmdvMV81Vk9TV0IwTXR6WHV6bWMxeGhzcV9GaE9EQ1ppR08tV05TaVgzdlJjYmZkclg4enZweTZGTmFTajRzbUFyd19hQWpNTnUzZG1KSEVuSFJBMEpfTW1uVmNlSE5NSQ?oc=5","date":"2025-08-08","type":"deal","source":"KED Global","summary":"LG Chem sells dermal filler business to VIG Partners for $144 mn - KED Global","headline":"LG Chem sells dermal filler business to VIG Partners for $144 mn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE8xbS1Ieko4c2RmUGx3bm9zaDl6d2ExR0t6X3FraDNfMGVyejhBV21RbHNXZVlTRUR5enl6aDhRTlJBNzl4ZmE3RGsyMFlvM2V4Y2ppU0hLYW5jOFQzZDdBRjN3Y1VFTHlrQjNYMkZ30gFyQVVfeXFMTUFITElJbEQxOS1YUXBkQ3ZoRnhCa09zV2pGNExXamkyaUk2S1hmd0ZXUTgzYnJiUXRDOGZCa2cyRVpzbk9rVFhfUWNOWUxYbktqN2hyd2toRFJFTTdEMUpDU3ZXRnVfSDlkMTF6QVozREJR?oc=5","date":"2025-08-07","type":"pipeline","source":"koreabiomed.com","summary":"LG Chem to sell aesthetics unit to PE firm for ₩200 billion - koreabiomed.com","headline":"LG Chem to sell aesthetics unit to PE firm for ₩200 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9DOTFBaER2cFJpYjZibVBHWWRxU21ULTB0aWI4aFhtbkNpQ3I3eFp0a2pGUkpyLUtLbmNicTlJQlFXc0EzMGZpQjA1WjlZX1VfNGt3?oc=5","date":"2025-07-09","type":"pipeline","source":"FirstWord Pharma","summary":"Rhythm's oral weight-loss contender exceeds expectations in niche obesity type - FirstWord Pharma","headline":"Rhythm's oral weight-loss contender exceeds expectations in niche obesity type","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1xN3EwYUZoV0p5MXB3WTN5RkttSG16eU5YdC1aS1JKN1lfRHZld2ZDXzhPYmEydXh4U3l5NzZXUzBZTEh4Y0FCNi1pMDdBbkZNak9pSHlaYTg2VElUd3hyN0NuaFAyWWsyQTVvckN30gFyQVVfeXFMTXhiNUI5dG4xTExXTHNCSjZodnN6LVpIYXVWZ0NuNFctWDZ5S0d3ZEt5eTE5LVo4YXUxVW84OG1QOE9sV0xoRVdkS294bFl1Y3ZmTWxUdC11YXNEVHRpMFl6a2JVWERlZFJfZ2I3RjUxeUp3?oc=5","date":"2025-07-01","type":"pipeline","source":"koreabiomed.com","summary":"LG Chem, Spark Biopharma to co-develop therapies for hard-to-treat diseases - koreabiomed.com","headline":"LG Chem, Spark Biopharma to co-develop therapies for hard-to-treat diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNQUpadzEwUW1NUUp1Y1hlQjJqVk80RjNESG9CN3laUnoyS3Q5X2otdlliYUV1dVFxcTA2SzEwVm9rMVlfTDQ1ai1IdTNiR0pPbnJ6SFg4OEJDb1Q4a25xTlVWZ09POE1JaG95RDJUZmZpTHR3b2dZTkZzRzdYT3ZEVGNNN0NxVW41V0lacmxSRzRBR0RuSzFTZnE0NkhFbmtRb1pKUnhhNTdab2M?oc=5","date":"2024-01-29","type":"pipeline","source":"massbio.org","summary":"Inspiring Science & Leading Innovation: A Pharma Day Q&A with LG Chem - massbio.org","headline":"Inspiring Science & Leading Innovation: A Pharma Day Q&A with LG Chem","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQeG83bWNVZU5vcjYwdTI3TDVmX1Z6RkxlV0gtNjBCMXZkakh6ampPVUpUWVNHNUZtZTZncWRXeFBFdkdCUTVQN0NCdm1jTDY5VkNhN2tfd1Y1OFhHcFhMeVhDS2I1RHRLblRYamtJanJZNjllSXREUDhFSE1JN0JTSm1pYzdUWTRZRUNlRGxKWVhyUEpKY25NTFZVeEQtdC1mVWtfZkFjSWFoMXBZNUh6MWh4RE4?oc=5","date":"2023-12-13","type":"pipeline","source":"massbio.org","summary":"Inspiring science and leading innovation at LG Chem AVEO Pharma Day® 2023 - massbio.org","headline":"Inspiring science and leading innovation at LG Chem AVEO Pharma Day® 2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFB1ZkpZQThhejFuRDc2SE1SeHk5dVpxS3RQZXhJOHBSYUYwc2E5UEJJeFdaNlBOcDNwUjAtUGZYTE1hWXNQMktKcTRiMFd0Zm9GTHhTWnJpLXFpaVRYT1ViLV9xV3hMZWpuZDloUkZ3?oc=5","date":"2023-11-15","type":"pipeline","source":"KED Global","summary":"South Korean bio, pharma industry set to take leap - KED Global","headline":"South Korean bio, pharma industry set to take leap","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNSnNrcGloWjA2NXhDNWVSLS1SQ1pWQjBFMDh5cXdfdU04T3VoX1V5SlQzaUZpOU52cy13MmhqMlhVR19TZUdtY3dxWHM1MWphSUZNWUpQZkZLWUhsZlgyWXJyLXJXTEtYYWRIWTU1bWVmckEzNTgxUlVsYWMzT3dLb0pDc0lxb0tnd3RVbVI3azY?oc=5","date":"2023-10-11","type":"pipeline","source":"pharmaphorum","summary":"South Korea: Emerging global leader in life sciences - pharmaphorum","headline":"South Korea: Emerging global leader in life sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOek1jTGpIWVFoT0JIcHlSYnJhb2VldDZCSHJ1QzJVdlZ6V2lBb1hFTUtWbXU5eUs4TTFvaE53SmRjSFZHdGI0aHJZUHpmcEFQdHdtbElQTHRhNl9GVDZsUmdCN085emxab0hYTHFxSXVPeF9oRDlocUxOY0sxSW1GVEtGdl9CT2VUdGhqeF9FZU1pb2NSc3c?oc=5","date":"2023-05-26","type":"pipeline","source":"Pharmaceutical Executive","summary":"Acquisition and Investment Spur AVEO Oncology to New Heights - Pharmaceutical Executive","headline":"Acquisition and Investment Spur AVEO Oncology to New Heights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNbTZCekFpQWZwbGdzeU53TlUzR19HXzdDcTFJTTh2cTROTjllaF9YSVpudy1ZOThjYUlSYWhTRUNRTU11WmJOZ0hSMXd5RVdpYlJzZjZheEFoSmxjWml0SHh5dDRSMkdCYXAtZF9Dc1FrVVhmZVEwVnh2RDVlYWZoQmNlamlEXzFWeERRbXVVUVRwR2V4TWxmR1RHMkE5SUhUZ1NF?oc=5","date":"2021-04-30","type":"regulatory","source":"Generics and Biosimilars Initiative","summary":"LG Chem gains approval for adalimumab biosimilar in Japan - Generics and Biosimilars Initiative","headline":"LG Chem gains approval for adalimumab biosimilar in Japan","sentiment":"positive"}],"patents":[],"drugCount":25,"phaseCounts":{"phase_1":3,"phase_3":14,"marketed":6,"phase_2":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}